Deficiencies of Rule-Based Technology-Generated Antibiograms for Specialized Care Units.

Antibiotics (Basel)

Department of Pharmacy, Regional One Health, Memphis, TN 38103, USA.

Published: June 2023

The objective of this study was to compare the pathogens and susceptibilities of the current automated, rule-based technology (RBT) antibiogram with one manually collected through chart review with additional rules applied. This study was a two-year, retrospective cohort study and included all bacterial cultures within the first 30 days from patients admitted to a single Burn Center. The current RBT antibiogram served as the control, and new antibiogram versions were created using additional rules and compared to the control. Six-hundred fifty-seven patients were admitted (61% excluded for lack of cultures). 59% had at least one hospital-acquired risk factor, with over one-third having recent illicit drug use and one-third having a recent hospitalization. Of the 410 cultures included, 57% were Gram-negative, and half were from wound infections. Sensitivities were significantly different when comparing the manual and the RBT version after including factors such as days since admission, presence of hospital-acquired risk factors, or previous antibiotic courses. Recommended empiric Gram-negative antibiotics changed from double coverage to a single β-lactam with >90% susceptibility. The susceptibilities between the first and subsequent courses were dramatically different. Before developing an antibiogram or interpreting the output, it is important to consider which automated criteria are utilized, especially for units with extended lengths of stay.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295712PMC
http://dx.doi.org/10.3390/antibiotics12061002DOI Listing

Publication Analysis

Top Keywords

rbt antibiogram
8
additional rules
8
patients admitted
8
hospital-acquired risk
8
deficiencies rule-based
4
rule-based technology-generated
4
technology-generated antibiograms
4
antibiograms specialized
4
specialized care
4
care units
4

Similar Publications

Low-level drug resistance in noncanonical pathways can constitute steppingstones toward acquisition of high-level on-target resistance mutations in the clinic. To capture these intermediate steps in (Mab), we performed classic mutant selection experiments with moxifloxacin at twofold its minimum inhibitory concentration (MIC) on solid medium. We found that low-level resistance emerged reproducibly as loss-of-function mutations in RshA (MAB_3542c), an anti-sigma factor that negatively regulates activity of SigH, which orchestrates a response to oxidative stress in mycobacteria.

View Article and Find Full Text PDF

Deficiencies of Rule-Based Technology-Generated Antibiograms for Specialized Care Units.

Antibiotics (Basel)

June 2023

Department of Pharmacy, Regional One Health, Memphis, TN 38103, USA.

The objective of this study was to compare the pathogens and susceptibilities of the current automated, rule-based technology (RBT) antibiogram with one manually collected through chart review with additional rules applied. This study was a two-year, retrospective cohort study and included all bacterial cultures within the first 30 days from patients admitted to a single Burn Center. The current RBT antibiogram served as the control, and new antibiogram versions were created using additional rules and compared to the control.

View Article and Find Full Text PDF

Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.

Mol Cell

September 2022

Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA; School of Public Health, University at Albany, Albany, NY 12208, USA. Electronic address:

Rifampicin (RIF), the frontline drug against M. tuberculosis, is completely ineffective against M. abscessus, partially due to the presence of an ADP-ribosyltransferase (Arr) that inactivates RIF.

View Article and Find Full Text PDF

Cationic chitosan@Ruthenium dioxide hybrid nanozymes for photothermal therapy enhancing ROS-mediated eradicating multidrug resistant bacterial infection.

J Colloid Interface Sci

December 2021

Department of Chemistry, College of Chemistry and Materials, Jinan University, Guangzhou 511436, People's Republic of China. Electronic address:

Antibiotic resistanceand biofilm formation are the main challenges of bacterial infectious diseases, and enhancing the permeability of drugs to biofilms may be a promising strategy. Herein, we constructed a cationic chitosan coated ruthenium dioxide nanozyme (QCS-RuO@RBT, SRT NSs)。RuO nanosheets (RuO NSs) are modified with positively charged Quaternary ammonium-chitosan (QCS) to improve biocompatibility, and enhance the interaction between RuO nanozymes and bacterial membranes. An antibacterial drug, [Ru(bpy)(tip)] (RBT) can be loaded onto QCS-RuO by π-π stacking and hydrophobic interaction.

View Article and Find Full Text PDF

Rifabutin Is Inactivated by Mycobacterium abscessus Arr.

Antimicrob Agents Chemother

February 2021

Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland

Article Synopsis
  • The text discusses rifampin resistance linked to ADP-ribosyltransferase (Arr), showing that some infections exhibit this resistance mechanism.* -
  • It suggests that rifabutin (RBT) shows promise as an alternative treatment because it seems unaffected by Arr, based on infection model findings.* -
  • The study proposes that improving RBT's effectiveness could involve making it resistant to Arr modifications or inhibiting Arr's activity altogether.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!